サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392327

免疫組織化学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Immunohistochemistry Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 170 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
免疫組織化学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫組織化学市場の世界需要は、2022年の51億1,000万米ドルから2030年には125億7,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは10.52%です。

免疫組織化学は、酵素、腫瘍抑制遺伝子、抗原、腫瘍細胞増殖の同定を診断や研究室で支援します。これには、異なる種類の細胞、生物学的サイクル、さらには複雑な組織内の細胞内局在における標的タンパク質の存在と局在の可視化が含まれます。IHCは、がん、感染症、心血管疾患、自己免疫疾患などの慢性疾患の診断に使用されるため、臨床診断において人気を博しています。IHCは研究用途にも使用され、目的の分子を細胞、分子、組織レベルで分析し、健康な細胞や組織と病気の細胞や組織の両方における役割を研究します。

市場力学：

慢性疾患の高い蔓延は、免疫組織化学ソリューションの需要を増加させ、市場の成長に寄与すると予想されます。さらに、より良い生活の質への関心の高まりと医療支出の増加が市場を押し上げると予想されます。そのほか、IHC技術は心臓病、医薬品開発、感染症、内分泌学、薬物乱用検査などの疾患の治療に使用され、市場を後押ししています。さらに、この技術はがん診断の形成に重要な役割を果たしています。その結果、がんの有病率の増加は免疫組織化学の需要を増加させ、市場の成長に寄与すると予想されます。しかし、IHC技術に伴う特異性の欠如とその高いセットアップコストが、免疫組織化学市場の成長を制限すると予想されます。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは免疫組織化学の世界市場における各セグメントを包括的に評価することもできます。免疫組織化学産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける免疫組織化学市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 免疫組織化学-産業分析

  • イントロダクション：市場力学
  • 市場の促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 免疫組織化学の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 抗体（一次抗体、二次抗体）
  • 機器（スライド染色システム、組織マイクロアレイ、組織処理システム、スライドスキャナー、その他）
  • 試薬（組織染色、ブロッキング血清・試薬、発色基質、固定試薬、安定剤、有機溶媒、タンパク質分解酵素、希釈剤、キット）

第7章 免疫組織化学の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 診断（がん、感染症、心血管疾患、自己免疫疾患、糖尿病、腎疾患）
  • 薬物検査

第8章 免疫組織化学の世界市場売上分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 病院・診断研究所
  • 研究機関
  • その他

第9章 免疫組織化学の世界市場売上分析：地域別

  • 地域別展望販売分析
  • イントロダクション売上分析
  • 北米売上分析
    • 概要、実績と予測
    • 北米セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第10章 免疫組織化学企業の競合情勢

  • 免疫組織化学市場の競合
  • 提携／共同研究／協定
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位10社のシェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Bio SB
  • Abcam plc.
  • Agilent Technologies Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
  • Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
  • Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
  • Drug Testing Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Immunohistochemistry Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Immunohistochemistry Report
  • Market Research Process
  • Market Research Methodology
  • Global Immunohistochemistry Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
  • Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
  • Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
  • Drug Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218525

The global demand for Immunohistochemistry Market is presumed to reach the market size of nearly USD 12.57 BN by 2030 from USD 5.11 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Immunohistochemistry (IHC) assists in diagnostic and research laboratories to identify enzymes, tumor suppressor genes, antigens, and tumor cell proliferation. It includes the visualization of the presence and localization of the target protein in different types of cells, biological cycles and even subcellular localization within the complex tissues. IHC has gained popularity in clinical diagnostics as it is used to diagnose chronic diseases such as cancer, infectious diseases, cardiovascular diseases, and autoimmune disorders. IHC is used in research applications where molecules of interest are analyzed on the cellular, molecular, or tissue level to study their roles in both healthy and diseased cells and tissues.

MARKET DYNAMICS:

The high prevalence of chronic diseases is expected to increase demand for immunohistochemistry solutions contributing to market growth. Moreover, the increased concern for experiencing a better quality of life and increased healthcare spending are expected to boost the market. Besides that, the IHC technique is used to treat diseases such as heart disease, drug development, infectious disease, endocrinology, and drug abuse testing, giving the market a boost. Furthermore, the technique has played an important role in shaping cancer diagnostics. As a result, the rising prevalence of cancer is expected to increase the demand for immunohistochemistry, thus contributing to market growth. However, the lack of specificity associated with IHC techniques and its high setup cost is anticipated to restrict the growth of the market for immunohistochemistry.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunohistochemistry. The growth and trends of immunohistochemistry industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the immunohistochemistry market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Antibodies (Primary Antibodies, Secondary Antibodies)
  • Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others)
  • Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits)

By Application

  • Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases)
  • Drug Testing

By End-Use

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Immunohistochemistry market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Immunohistochemistry market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Abcam plc., Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IMMUNOHISTOCHEMISTRY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Antibodies (Primary Antibodies, Secondary Antibodies) Historic and Forecast Sales by Regions
  • 6.5 Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Historic and Forecast Sales by Regions
  • 6.6 Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Historic and Forecast Sales by Regions

7 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Historic and Forecast Sales by Regions
  • 7.5 Drug Testing Historic and Forecast Sales by Regions

8 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 8.5 Research Institutes Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE IMMUNOHISTOCHEMISTRY COMPANIES

  • 10.1. Immunohistochemistry Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF IMMUNOHISTOCHEMISTRY INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. F. Hoffmann-La Roche Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Merck KGaA
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Danaher Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. PerkinElmer Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Bio-Rad Laboratories Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Cell Signaling Technology Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Bio SB
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Abcam plc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Agilent Technologies Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies